Rapid Therapeutic Science Laboratories, Inc. — Form D
Rapid Therapeutic Science Laboratories, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-07. The offering totals $4.0M, of which $1.3M was reported sold. Industry: Other.
Offering
- Filed: 2020-12-07
- Form: D
- Accession: 0001393905-20-000351
- Industry: Other
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.3M
- Remaining: $2.7M
- Minimum investment: $1K
- Investors: 42
- Date of first sale: 2020-03-27
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-382360
Issuer
- Name: Rapid Therapeutic Science Laboratories, Inc.
- CIK: 0001575659
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 5580 PETERSON LANE, DALLAS, TX, 75240
- Phone: 214-236-1363
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| D. Hughes R Watler | Director | DALLAS, TX |
| D. Hughes R Watler | Executive Officer | DALLAS, TX |
| Donal R Schmidt | Director | DALLAS, TX |
| Donal R Schmidt | Executive Officer | DALLAS, TX |
Other filings by this issuer (2)
More